Outcome of allogeneic haematopoietic stem cell transplant for philadelphia chromosome positive acute lymphoblastic leukaemia in paediatric patients in the era of tyrosine kinase inhibitors and strategies for management of relapse: a UK multicentre study

被引：0
|
作者：
Furness, C. L. [1 ]
Ethell, M. E. [1 ]
Saha, V. [2 ]
Parker, C. [2 ]
Vora, A. J. [3 ]
Skinner, R. [4 ]
Amrolia, P. J. [5 ]
Veys, P. [5 ]
Lawson, S. [6 ]
Potter, M. N. [1 ]
机构：
[1] Royal Marsden Hosp, Dept Haematooncol, Sutton, Surrey, England
[2] Manchester Acad Hlth Sci Ctr, Childrens Canc Grp, Ctr Paediat Teenage & Young Adult Canc, Inst Canc, Manchester, Lancs, England
[3] Sheffield Childrens Hosp, Dept Paediat Hematol, Sheffield, S Yorkshire, England
[4] Royal Victoria Infirm, Dept Paediat Oncol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
[5] Great Ormond St Hosp Sick Children, Dept Bone Marrow Transplant, London WC1N 3JH, England
[6] Birmingham Childrens Hosp, Dept Paediat Haematol, Birmingham, W Midlands, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2013年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
19
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [21] Improved outcome of allogeneic haemopoietic stem cell transplantation for children with philadelphia positive acute lymphoblastic leukaemia
    Garg, Anshu
    Sankar, Adhithya
    Williams, Janet
    Astwood, Emma
    Payne, Jeanette
    Welch, Jenny
    Rush, Shan
    Marples, Julie
    Barrott, Sharon
    Vora, Ajay
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 157 (02) : 261 - 263
  • [22] Sustained complete molecular response and low treatment related mortality after allogeneic haematopoietic stem cell transplantation for Philadelphia-positive acute lymphoblastic leukaemia patients previously treated with tyrosine kinase inhibitors
    de lavallade, H.
    Prebet, T.
    El Cheikh, J.
    Faucher, C.
    Vey, N.
    Charbonnier, A.
    Chabannon, C.
    Blaise, D.
    Furst, S.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S99 - S99
  • [23] Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO)
    Candoni, Anna
    Rambaldi, Alessandro
    Fanin, Renato
    Velardi, Andrea
    Arcese, William
    Ciceri, Fabio
    lazzarotto, Davide
    Lussana, Federico
    Olivieri, Jacopo
    Grillo, Giovanni
    Parma, Matteo
    Bruno, Benedetto
    Sora, Federica
    Bernasconi, Paolo
    Saccardi, Riccardo
    Foa, Robin
    Sessa, Mariarosa
    Bresciani, Paola
    Giglio, Fabio
    Picardi, Alessandra
    Busca, Alessandro
    Sica, Simona
    Perruccio, Katia
    Zucchetti, Elisa
    Diral, Elisa
    Iori, Anna Paola
    Colombo, Anna Amelia
    Tringali, Stefano
    Santarone, Stella
    Irrera, Giuseppe
    Mancini, Stefano
    Zallio, Francesco
    Malagola, Michele
    Albano, Francesco
    Carella, Angelo Michele
    Olivieri, Attilio
    Tecchio, Cristina
    Dominietto, Alida
    Vacca, Adriana
    Sorasio, Roberto
    Orciuolo, Enrico
    Risitano, Antonio Maria
    Leotta, Salvatore
    Cortelezzi, Agostino
    Mammoliti, Sonia
    Oldani, Elena
    Bonifazi, Francesca
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (12) : 2388 - 2397
  • [24] Tyrosine kinase inhibitor therapy or transplant in children with Philadelphia chromosome-positive acute lymphoblastic leukaemia: striking the balance
    Ottmann, Oliver
    LANCET HAEMATOLOGY, 2018, 5 (12): : E606 - E607
  • [25] Discontinuation of Maintenance Tyrosine Kinase Inhibitors in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia outside of Transplant
    Samra, Bachar
    Kantarjian, Hagop M.
    Sasaki, Koji
    Alotaibi, Ahmad S.
    Konopleva, Marina
    O'Brien, Susan
    Ferrajoli, Alessandra
    Garris, Rebecca
    Nunez, Cesar A.
    Kadia, Tapan M.
    Short, Nicholas J.
    Jabbour, Elias
    ACTA HAEMATOLOGICA, 2021, 144 (03) : 285 - 292
  • [26] Tyrosine Kinase Inhibitor Treatment after Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
    Chang, Yu-Hsiang
    Liao, Xiu-Wen
    Liu, Jia-Hau
    Yao, Ming
    Ko, Bor-Sheng
    Li, Chi-Cheng
    Tsai, Cheng-Hong
    Wu, Shang-Ju
    Huang, Hui-Hsuan
    Huang, Tai-Chung
    Hou, Hsin-An
    Chou, Wen-Chien
    Tien, Feng-Ming
    Lin, Yun-Chu
    Lu, Meng-Yao
    Lin, Kai-Hsin
    Tang, Jih-Luh
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 201 - 202
  • [27] A decision analysis of allogeneic haematopoietic stem cell transplantation for adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia in first remission
    Kako, S.
    Morita, S.
    Sakamaki, H.
    Iida, H.
    Kurokawa, M.
    Miyamura, K.
    Ogawa, H.
    Fukuda, T.
    Takahashi, S.
    Kanamori, H.
    Atsuta, Y.
    Morishima, Y.
    Jinnai, I.
    Takeuchi, J.
    Miyazaki, Y.
    Miyawaki, S.
    Onishi, K.
    Naoe, T.
    Kanda, Y.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S87 - S88
  • [28] REDUCED INTENSITY CHEMOTHERAPY WITH TYROSINE KINASE INHIBITOR FOLLOWED BY ALLOGENEIC STEM CELL TRANSPLANTATION WAS EFFECTIVE IN PATIENTS WITH PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA
    Baek, Dong Won
    Lee, Jung Min
    Choi, Hyukjin
    Moon, Joon Ho
    Sohn, Sang Kyun
    BONE MARROW TRANSPLANTATION, 2024, 59 : 170 - 170
  • [29] Retrospective analysis of Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic hematopoietic stem cell transplant versus chemotherapy combined with tyrosine kinase inhibitor
    Togasaki, Emi
    Shono, Katsuhiro
    Onoda, Masahiro
    Yokota, Akira
    LEUKEMIA & LYMPHOMA, 2015, 56 (01) : 244 - 247
  • [30] Outcome of sibling allogeneic stem cell transplant for Philadelphia positive (Ph plus ) acute leukaemia with different phenotypes
    Mohamed, S. Y.
    AlZahrani, H.
    Melhan, H.
    Chaudari, N.
    Ibrahim, K.
    El-Gohary, G.
    Almohareb, F.
    Younis, R.
    Walter, C.
    AlJurf, M.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S103 - S104
12345